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Abstract 
 
This dissertation describes three chemical-scale studies of neuroreceptor structure 
and function.  Incorporation of unnatural amino acids into two acetylcholine receptors—
the nicotinic acetylcholine receptor (nAChR) and the M2 muscarinic acetylcholine 
receptor (M2AChR)—and an electrophysiology assay of receptor function were 
performed in each of the studies.  The nAChR is a ligand-gated ion channel (LGIC) and 
the M2AChR is a G-protein-coupled receptor (GPCR). 
In Chapter 2, a highly conserved aspartate residue (D89) that is near the agonist 
binding site of the nAChR was probed for its role in agonist binding.  We found that the 
side chain of D89 establishes a redundant network of hydrogen bonds and preorganizes 
the agonist binding site by positioning a critical agonist-binding residue, tryptophan 149 
(W149).  Previous studies of a D89N mutant led to the proposal that a negative charge at 
D89 was essential for receptor function.  However, our studies show that neutral side 
chains at position 89 function well, only if an unfavorable electrostatic clash is avoided. 
Chapter 3 describes our attempts to incorporate unnatural amino acids into the 
M2AChR, a GPCR.  GPCR activity is assayed through second messenger signaling 
pathways, unlike the direct readout assays of LGICs.  These second messenger pathways 
require significant amounts of optimization to create assays that produce reliable and 
robust data.  In our experiments, variability of dose-response relationship data between 
batches of cells was the most significant concern.  Several factors were investigated to 
reduce this batch-to-batch variability.  After a reliable means to assay M2AChR function 
viii 
was found, we performed a preliminary search for tryptophan residues in the agonist 
binding site that form a cation-π interaction with acetylcholine. 
Finally, in Chapter 4, we discuss the use of hydroxy acids to scan the αM1 
transmembrane helix of the nAChR for residues that undergo structural rearrangements 
during gating.  Hydroxy acids disrupt hydrogen bonding in protein backbones and thus 
provide a means to detect backbone interactions that form or break during gating.  The 
hydroxy acid analog of valine, valic acid (Vah), was incorporated at ten positions along 
the αM1 helix.  Backbone mutations at five residues on the intracellular side of a 
conserved proline (P221) produced shifts in dose-response relationships.   
ix 
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